AIG
FHTX icon

American International Group’s Foghorn Therapeutics FHTX Stock Holding History

American International Group’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,018
Closed -$67.2K – 971
2024
Q1 		$67.2K Sell
10,018
-86
-0.9% -$477 ﹤0.01% 2702
2023
Q4 		$65.2K Sell
10,104
-41
-0.4% -$177 ﹤0.01% 2750
2023
Q3 		$50.7K Buy
10,145
+360
+4% +$2.77K ﹤0.01% 2812
2023
Q2 		$68.9K Buy
9,785
+87
+0.9% +$608 ﹤0.01% 2783
2023
Q1 		$60.1K Buy
9,698
+192
+2% +$1.26K ﹤0.01% 2659
2022
Q4 		$60.6K Sell
9,506
-34
-0.4% -$256 ﹤0.01% 2690
2022
Q3 		$82K Buy
9,540
+135
+1% +$1.74K ﹤0.01% 2645
2022
Q2 		$128K Sell
9,405
-307
-3% -$3.96K ﹤0.01% 2445
2022
Q1 		$148K Sell
9,712
-683
-7% -$9.37K ﹤0.01% 2421
2021
Q4 		$238K Sell
10,395
-311
-3% -$4.47K ﹤0.01% 2265
2021
Q3 		$149K Sell
10,706
-254
-2% -$2.81K ﹤0.01% 2598
2021
Q2 		$117 Buy
10,960
+6,768
+161% +$73.7K ﹤0.01% 2821
2021
Q1 		$55 Buy
4,192
+11
+0.3% +$180 ﹤0.01% 2960
2020
Q4 		$85 Buy
+4,181
New +$80.1K ﹤0.01% 2740

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

American International Group's FHTX Position: Q2 2024 in Review

American International Group sold out of Foghorn Therapeutics (FHTX) in Q2 2024, closing a stake of 10,018 shares — an estimated $67.2K sold.

American International Group first reported a position in FHTX in Q4 2020 and held it in 14 quarters. The position peaked at $238K in Q4 2021. 72 funds tracked by Wall St. Rank hold FHTX as of Q2 2024.

  • American International Group reported no remaining Foghorn Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 10,018 Foghorn Therapeutics shares in Q2 2024, an estimated $67.2K.
  • American International Group first reported a position in Foghorn Therapeutics in Q4 2020 and held it in 14 quarters.
  • American International Group's Foghorn Therapeutics position peaked at $238K in Q4 2021.
  • 72 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.